Skip to content

Clinical trials

Carcinoma, Transitional Cell trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Transitional Cell Country / region: Canada Clear all

61 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20054
20061
20071
20082
20101
20112
20152
20165
20174
20182
20197
20205
20215
20226
20236
20242
20254
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Active, not recruiting11
Terminated11
Recruiting10
Unknown status2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb5
Merck Sharp & Dohme LLC5
Pfizer4
Astellas Pharma Global Development, Inc.3
AstraZeneca2
Bioniche Life Sciences Inc.2
Eli Lilly and Company2
Genentech, Inc.2
Hoffmann-La Roche2
Incyte Corporation2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Transitional Cell61
Urinary Bladder Neoplasms34
Carcinoma, Non-Small-Cell Lung10
Carcinoma, Renal Cell9
Melanoma8
Neoplasm Metastasis8
Squamous Cell Carcinoma of Head and Neck8
Neoplasms7
Urologic Neoplasms6
Uterine Cervical Neoplasms6

Trials

Showing 1 to 25 of 61. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.